Global and United States Insomnia Therapy Market Report & Forecast 2024-2031

Report ID: 1838296 | Published Date: Sep 2024 | No. of Page: 112 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
1 Study Coverage
    1.1 Insomnia Therapy Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Insomnia Therapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Insomnia Therapy Market Size for the Year 2017-2028
        1.2.2 Global Insomnia Therapy Market Size for the Year 2017-2028
    1.3 Insomnia Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Insomnia Therapy in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Insomnia Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Insomnia Therapy Market Dynamics
        1.4.1 Insomnia Therapy Industry Trends
        1.4.2 Insomnia Therapy Market Drivers
        1.4.3 Insomnia Therapy Market Challenges
        1.4.4 Insomnia Therapy Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Insomnia Therapy by Type
    2.1 Insomnia Therapy Market Segment by Type
        2.1.1 Non-pharmacological Therapy
        2.1.2 Pharmacological Therapy
    2.2 Global Insomnia Therapy Market Size by Type (2017, 2022 & 2028)
    2.3 Global Insomnia Therapy Market Size by Type (2017-2028)
    2.4 United States Insomnia Therapy Market Size by Type (2017, 2022 & 2028)
    2.5 United States Insomnia Therapy Market Size by Type (2017-2028)
3 Insomnia Therapy by Application
    3.1 Insomnia Therapy Market Segment by Application
        3.1.1 Hospital
        3.1.2 Ambulatory Surgical Center
        3.1.3 Home Care
    3.2 Global Insomnia Therapy Market Size by Application (2017, 2022 & 2028)
    3.3 Global Insomnia Therapy Market Size by Application (2017-2028)
    3.4 United States Insomnia Therapy Market Size by Application (2017, 2022 & 2028)
    3.5 United States Insomnia Therapy Market Size by Application (2017-2028)
4 Global Insomnia Therapy Competitor Landscape by Company
    4.1 Global Insomnia Therapy Market Size by Company
        4.1.1 Top Global Insomnia Therapy Companies Ranked by Revenue (2021)
        4.1.2 Global Insomnia Therapy Revenue by Player (2017-2022)
    4.2 Global Insomnia Therapy Concentration Ratio (CR)
        4.2.1 Insomnia Therapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Insomnia Therapy in 2021
        4.2.3 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Insomnia Therapy Headquarters, Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Insomnia Therapy Headquarters and Area Served
        4.3.2 Global Insomnia Therapy Companies Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Insomnia Therapy Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Insomnia Therapy Market Size by Company
        4.5.1 Top Insomnia Therapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Insomnia Therapy Revenue by Players (2020, 2021 & 2022)
5 Global Insomnia Therapy Market Size by Region
    5.1 Global Insomnia Therapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Insomnia Therapy Market Size by Region (2017-2028)
        5.2.1 Global Insomnia Therapy Market Size by Region: 2017-2022
        5.2.2 Global Insomnia Therapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Insomnia Therapy Market Size YoY Growth 2017-2028
        6.1.2 North America Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Insomnia Therapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Insomnia Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Insomnia Therapy Market Size YoY Growth 2017-2028
        6.3.2 Europe Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Insomnia Therapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Insomnia Therapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Insomnia Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Merck & Co.
        7.1.1 Merck & Co. Company Details
        7.1.2 Merck & Co. Business Overview
        7.1.3 Merck & Co. Insomnia Therapy Introduction
        7.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2017-2022)
        7.1.5 Merck & Co. Recent Development
    7.2 Sanofi
        7.2.1 Sanofi Company Details
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Insomnia Therapy Introduction
        7.2.4 Sanofi Revenue in Insomnia Therapy Business (2017-2022)
        7.2.5 Sanofi Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Company Details
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Insomnia Therapy Introduction
        7.3.4 Pfizer Revenue in Insomnia Therapy Business (2017-2022)
        7.3.5 Pfizer Recent Development
    7.4 Takeda Pharmaceutical Company Ltd.
        7.4.1 Takeda Pharmaceutical Company Ltd. Company Details
        7.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
        7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
        7.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2017-2022)
        7.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
    7.5 Purdue Pharmaceuticals L.P.
        7.5.1 Purdue Pharmaceuticals L.P. Company Details
        7.5.2 Purdue Pharmaceuticals L.P. Business Overview
        7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
        7.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2017-2022)
        7.5.5 Purdue Pharmaceuticals L.P. Recent Development
    7.6 Eisai, Co. Ltd.
        7.6.1 Eisai, Co. Ltd. Company Details
        7.6.2 Eisai, Co. Ltd. Business Overview
        7.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
        7.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2017-2022)
        7.6.5 Eisai, Co. Ltd. Recent Development
    7.7 Meda Consumer Healthcare
        7.7.1 Meda Consumer Healthcare Company Details
        7.7.2 Meda Consumer Healthcare Business Overview
        7.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
        7.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2017-2022)
        7.7.5 Meda Consumer Healthcare Recent Development
    7.8 Pernix Therapeutics
        7.8.1 Pernix Therapeutics Company Details
        7.8.2 Pernix Therapeutics Business Overview
        7.8.3 Pernix Therapeutics Insomnia Therapy Introduction
        7.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2017-2022)
        7.8.5 Pernix Therapeutics Recent Development
    7.9 Vanda Pharmaceuticals
        7.9.1 Vanda Pharmaceuticals Company Details
        7.9.2 Vanda Pharmaceuticals Business Overview
        7.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
        7.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022)
        7.9.5 Vanda Pharmaceuticals Recent Development
    7.10 ECR Pharmaceuticals
        7.10.1 ECR Pharmaceuticals Company Details
        7.10.2 ECR Pharmaceuticals Business Overview
        7.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
        7.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022)
        7.10.5 ECR Pharmaceuticals Recent Development
    7.11 Fidia Farmaceutici
        7.11.1 Fidia Farmaceutici Company Details
        7.11.2 Fidia Farmaceutici Business Overview
        7.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
        7.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2017-2022)
        7.11.5 Fidia Farmaceutici Recent Development
    7.12 Dainippon Sumitomo
        7.12.1 Dainippon Sumitomo Company Details
        7.12.2 Dainippon Sumitomo Business Overview
        7.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
        7.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2017-2022)
        7.12.5 Dainippon Sumitomo Recent Development
    7.13 Biocodex
        7.13.1 Biocodex Company Details
        7.13.2 Biocodex Business Overview
        7.13.3 Biocodex Insomnia Therapy Introduction
        7.13.4 Biocodex Revenue in Insomnia Therapy Business (2017-2022)
        7.13.5 Biocodex Recent Development
    7.14 Eli Lilly and Company
        7.14.1 Eli Lilly and Company Company Details
        7.14.2 Eli Lilly and Company Business Overview
        7.14.3 Eli Lilly and Company Insomnia Therapy Introduction
        7.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2017-2022)
        7.14.5 Eli Lilly and Company Recent Development
    7.15 Ebb Therapeutics
        7.15.1 Ebb Therapeutics Company Details
        7.15.2 Ebb Therapeutics Business Overview
        7.15.3 Ebb Therapeutics Insomnia Therapy Introduction
        7.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2017-2022)
        7.15.5 Ebb Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Insomnia Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Insomnia Therapy Market Trends
    Table 3. Insomnia Therapy Market Drivers
    Table 4. Insomnia Therapy Market Challenges
    Table 5. Insomnia Therapy Market Restraints
    Table 6. Global Insomnia Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Insomnia Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Insomnia Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Insomnia Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Insomnia Therapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Insomnia Therapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Insomnia Therapy Revenue Share by Player, 2017-2022
    Table 13. Global Insomnia Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Insomnia Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2021)
    Table 15. Top Players of Insomnia Therapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Insomnia Therapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Insomnia Therapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Insomnia Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Insomnia Therapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Insomnia Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Insomnia Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Insomnia Therapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Insomnia Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Insomnia Therapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Insomnia Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Insomnia Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Insomnia Therapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Merck & Co. Company Details
    Table 31. Merck & Co. Business Overview
    Table 32. Merck & Co. Insomnia Therapy Product
    Table 33. Merck & Co. Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 34. Merck & Co. Recent Development
    Table 35. Sanofi Company Details
    Table 36. Sanofi Business Overview
    Table 37. Sanofi Insomnia Therapy Product
    Table 38. Sanofi Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 39. Sanofi Recent Development
    Table 40. Pfizer Company Details
    Table 41. Pfizer Business Overview
    Table 42. Pfizer Insomnia Therapy Product
    Table 43. Pfizer Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 44. Pfizer Recent Development
    Table 45. Takeda Pharmaceutical Company Ltd. Company Details
    Table 46. Takeda Pharmaceutical Company Ltd. Business Overview
    Table 47. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
    Table 48. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 49. Takeda Pharmaceutical Company Ltd. Recent Development
    Table 50. Purdue Pharmaceuticals L.P. Company Details
    Table 51. Purdue Pharmaceuticals L.P. Business Overview
    Table 52. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
    Table 53. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 54. Purdue Pharmaceuticals L.P. Recent Development
    Table 55. Eisai, Co. Ltd. Company Details
    Table 56. Eisai, Co. Ltd. Business Overview
    Table 57. Eisai, Co. Ltd. Insomnia Therapy Product
    Table 58. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 59. Eisai, Co. Ltd. Recent Development
    Table 60. Meda Consumer Healthcare Company Details
    Table 61. Meda Consumer Healthcare Business Overview
    Table 62. Meda Consumer Healthcare Insomnia Therapy Product
    Table 63. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 64. Meda Consumer Healthcare Recent Development
    Table 65. Pernix Therapeutics Company Details
    Table 66. Pernix Therapeutics Business Overview
    Table 67. Pernix Therapeutics Insomnia Therapy Product
    Table 68. Pernix Therapeutics Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 69. Pernix Therapeutics Recent Development
    Table 70. Vanda Pharmaceuticals Company Details
    Table 71. Vanda Pharmaceuticals Business Overview
    Table 72. Vanda Pharmaceuticals Insomnia Therapy Product
    Table 73. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 74. Vanda Pharmaceuticals Recent Development
    Table 75. ECR Pharmaceuticals Company Details
    Table 76. ECR Pharmaceuticals Business Overview
    Table 77. ECR Pharmaceuticals Insomnia Therapy Product
    Table 78. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 79. ECR Pharmaceuticals Recent Development
    Table 80. Fidia Farmaceutici Company Details
    Table 81. Fidia Farmaceutici Business Overview
    Table 82. Fidia Farmaceutici Insomnia Therapy Product
    Table 83. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 84. Fidia Farmaceutici Recent Development
    Table 85. Dainippon Sumitomo Company Details
    Table 86. Dainippon Sumitomo Business Overview
    Table 87. Dainippon Sumitomo Insomnia Therapy Product
    Table 88. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 89. Dainippon Sumitomo Recent Development
    Table 90. Biocodex Company Details
    Table 91. Biocodex Business Overview
    Table 92. Biocodex Insomnia Therapy Product
    Table 93. Biocodex Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 94. Biocodex Recent Development
    Table 95. Eli Lilly and Company Company Details
    Table 96. Eli Lilly and Company Business Overview
    Table 97. Eli Lilly and Company Insomnia Therapy Product
    Table 98. Eli Lilly and Company Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 99. Eli Lilly and Company Recent Development
    Table 100. Ebb Therapeutics Company Details
    Table 101. Ebb Therapeutics Business Overview
    Table 102. Ebb Therapeutics Insomnia Therapy Product
    Table 103. Ebb Therapeutics Revenue in Insomnia Therapy Business (2017-2022) & (US$ Million)
    Table 104. Ebb Therapeutics Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insomnia Therapy Product Picture
    Figure 2. Global Insomnia Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Insomnia Therapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Insomnia Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Insomnia Therapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Insomnia Therapy Market Share in Global 2017-2028
    Figure 7. Insomnia Therapy Report Years Considered
    Figure 8. Product Picture of Non-pharmacological Therapy
    Figure 9. Product Picture of Pharmacological Therapy
    Figure 10. Global Insomnia Therapy Market Share by Type in 2022 & 2028
    Figure 11. Global Insomnia Therapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Insomnia Therapy Market Share by Type (2017-2028)
    Figure 13. United States Insomnia Therapy Market Share by Type in 2022 & 2028
    Figure 14. United States Insomnia Therapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Insomnia Therapy Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Ambulatory Surgical Center
    Figure 18. Product Picture of Home Care
    Figure 19. Global Insomnia Therapy Market Share by Application in 2022 & 2028
    Figure 20. Global Insomnia Therapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Insomnia Therapy Market Share by Application (2017-2028)
    Figure 22. United States Insomnia Therapy Market Share by Application in 2022 & 2028
    Figure 23. United States Insomnia Therapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Insomnia Therapy Market Share by Application (2017-2028)
    Figure 25. North America Insomnia Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Insomnia Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Insomnia Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Insomnia Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Insomnia Therapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Insomnia Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 54. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 55. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 56. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 57. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 58. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 59. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 60. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 61. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 62. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 63. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 64. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 65. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 66. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 67. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Frequently Asked Questions
Insomnia Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Insomnia Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Insomnia Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Umbrella Stand

Umbrella Stand market is segmented by region (country), players, by Type and by Application. Play ... Read More